IFP Advisors’s Alexion Pharmaceuticals Inc ALXN Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2021
Q3 | – | Sell |
-240
| Closed | -$45K | – | 5047 |
|
2021
Q2 | $45K | Buy |
240
+23
| +11% | +$4.31K | ﹤0.01% | 1576 |
|
2021
Q1 | $32K | Sell |
217
-43
| -17% | -$6.34K | ﹤0.01% | 1636 |
|
2020
Q4 | $40K | Sell |
260
-1
| -0.4% | -$154 | ﹤0.01% | 1531 |
|
2020
Q3 | $30K | Sell |
261
-37
| -12% | -$4.25K | ﹤0.01% | 1483 |
|
2020
Q2 | $33K | Sell |
298
-13
| -4% | -$1.44K | ﹤0.01% | 1388 |
|
2020
Q1 | $26K | Buy |
311
+7
| +2% | +$585 | ﹤0.01% | 1387 |
|
2019
Q4 | $32K | Buy |
304
+54
| +22% | +$5.68K | ﹤0.01% | 1435 |
|
2019
Q3 | $24K | Buy |
+250
| New | +$24K | ﹤0.01% | 1699 |
|
2019
Q1 | $4K | Sell |
34
-318
| -90% | -$37.4K | ﹤0.01% | 1964 |
|
2018
Q4 | $34K | Buy |
352
+79
| +29% | +$7.63K | ﹤0.01% | 1821 |
|
2018
Q3 | $38K | Sell |
273
-41
| -13% | -$5.71K | ﹤0.01% | 2037 |
|
2018
Q2 | $39K | Sell |
314
-484
| -61% | -$60.1K | ﹤0.01% | 2057 |
|
2018
Q1 | $95K | Hold |
798
| – | – | ﹤0.01% | 1418 |
|
2017
Q4 | $95K | Buy |
798
+154
| +24% | +$18.3K | ﹤0.01% | 1416 |
|
2017
Q3 | $90K | Buy |
644
+208
| +48% | +$29.1K | ﹤0.01% | 1611 |
|
2017
Q2 | $53K | Sell |
436
-74
| -15% | -$9K | ﹤0.01% | 1920 |
|
2017
Q1 | $62K | Sell |
510
-17
| -3% | -$2.07K | ﹤0.01% | 1790 |
|
2016
Q4 | $64K | Buy |
527
+51
| +11% | +$6.19K | ﹤0.01% | 1734 |
|
2016
Q3 | $58K | Buy |
476
+68
| +17% | +$8.29K | ﹤0.01% | 1711 |
|
2016
Q2 | $48K | Buy |
408
+374
| +1,100% | +$44K | ﹤0.01% | 1783 |
|
2016
Q1 | $4K | Sell |
34
-129
| -79% | -$15.2K | ﹤0.01% | 1964 |
|
2015
Q4 | $31K | Buy |
+163
| New | +$31K | ﹤0.01% | 1888 |
|